Related Experiment Videos
Cephalothin prophylaxis assay during cardiopulmonary bypass
The Journal of Thoracic and Cardiovascular Surgery
|February 1, 1976
Summary
Prophylactic antibiotics ensure adequate surgical site infection prevention. This study found that current cardiothoracic antibiotic regimens, including cephalothin dosing, provide sufficient coverage during cardiopulmonary bypass.
Area of Science:
- Cardiothoracic Surgery
- Pharmacokinetics
- Infectious Disease Prevention
Background:
- Prophylactic antibiotics are crucial for preventing surgical site infections.
- Antibiotic levels must be adequate during maximal contamination risk, especially during cardiac surgery.
- Cardiopulmonary bypass presents unique challenges for maintaining effective antibiotic concentrations.
Purpose of the Study:
- To evaluate the adequacy of antibiotic coverage during cardiothoracic surgical procedures.
- To assess antibiotic levels, specifically cephalothin, during cardiopulmonary bypass.
- To ensure optimal antibiotic prophylaxis in cardiac surgery patients.
Main Methods:
- Prospective study of 12 consecutive cardiothoracic surgery patients.
- Monitoring of antibiotic serum concentrations throughout the surgical procedure.
- Analysis of antibiotic levels during and after cardiopulmonary bypass.
Main Results:
- The established antibiotic regimen generally provided adequate coverage.
- A reinforcing cephalothin dose post-bypass ensured sufficient circulating levels.
- Cephalothin clearance from blood was significantly reduced during cardiopulmonary bypass.
Conclusions:
- The studied antibiotic regimen is effective for cardiothoracic surgery.
- Specific dosing strategies, including post-bypass reinforcement, are vital.
- Pharmacokinetic changes during cardiopulmonary bypass necessitate careful antibiotic management.